Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate…
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care Insulet Corporation the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its…
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ:…
Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting…
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III…
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio Hologic, Inc. announced today that its Aptima® HPV Assay received FDA approval for clinician-collected HPV primary screening.…
Aya Locums’ Physician Assistant Named a “2025 Locum Tenens Providers of the Year” by Locumpedia Locumpedia named Alain Raymond, PA-C, a cardiothoracic surgical physician assistant with Aya Locums and a…
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management Dexcom, Inc. the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled…
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched…
Clarest Health Launches “Clarest at Home,” Closing the Gap in Medication Management from Facility to Front Door Clarest Health, a leader in personalized medication management, announced the launch of Clarest at…
Nubeqa™ (Darolutamide) Gains Third Approval in China for Treatment of Advanced Prostate Cancer in Men The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi)…
Bristol Myers Squibb Launches “Change the Target. Change What’s Possible.” Campaign to Address Unmet Needs in Cardiovascular and Thromboembolic Care Bristol Myers Squibb announced today the launch of “Change the Target.…
